X
CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19). Learn More

Biopsy

A prostate biopsy, also known as a core needle biopsy or a transrectal ultrasound (TRUS), is used to determine if any suspicious looking tissues are cancerous or not. A biopsy is conducted when an abnormal lump is found during a digital rectal exam (DRE) or if the prostate-specific antigen (PSA) blood test reveals high levels of PSA.

Prostate Cancer Canada graciously acknowledges the Princess Margaret Cancer Centre for sharing this video with us.
 
How is a biopsy performed?
  • You will be given a local anesthetic. 
  • A biopsy needle and ultrasound probe is then inserted into your rectum. Your doctor will use the ultrasound as a visual aid to help him/her guide the needle through your rectum. The needle quickly pierces through the rectal wall, enters the prostate and removes a tissue sample.
  • 8-12 samples will be taken depending on the area to be examined.
  • Procedure lasts between 15 and 20 minutes. 
What can I expect after the procedure?
 
Everyone responds differently to procedures. Following a prostate biopsy, it is common to experience the following:
  • Bleeding from your rectum or penis
  • Blood in the stool, urine or semen
  • Pain
These common symptoms may persist for 2 weeks or more. If you have concerns about these symptoms, discuss them with your doctor.


 

For more information and support:

Prostate Cancer Canada and Canadian Cancer Society








Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.
More

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More


Click here for news archive